A Comparison of Vaginal Artery Vascularization in Postmenopausal Women with and without Genitourinary Syndrome of Menopause: A Cross-sectional Analytic Study

Authors

  • Patsira Warinsiriruk Department of Obstetrics and Gynecology, Chaophrayayommarat Hospital Suphanburi

Keywords:

Vaginal Artery Vascularization, Postmenopausal women, Genitourinary Syndrome of Menopause

Abstract

This study aims to compare vaginal blood flow (PI,RI), Vaginal Health Index (VHI) between postmenopausal women with and without Genitourinary Syndrome of Menopause (GSM). A Cross-Sectional Analytic study was conducted among 44 postmenopausal women at Menopausal clinic, Chaophrayayommarat Hospital from January to June 2024. The Pulsatile index (PI), Resistance index (RI), Vaginal Health Index (VHI) were measured. Pulsatility index (PI) and resistance index (RI) were measured using a Voluson™ P6 ultrasound system. Inter- and intra-observer reliability were assessed to ensure measurement reliability. Group differences were analyzed using the Mann – Whitney U test, and associations were evaluated using the Chi - square test.

The results revealed that the characteristics between two groups were similar in age, body mass index, menopause period and para. The Pulsatile index (PI) in postmenopausal women with GSM was significant higher than without GSM (6.34 + 2.21 and 3.31 + 1.19; p = 0.002). Similarly, RIs in GSM group and non-GSM group were 5.66 + 2.23 and 2.31 + 0.98 (p = 0.001), respectively. In addition, all parameters of VHI based on vaginal physical findings in GSM group were significant lower than non-GSM group (p < 0.001).

In conclusion, the postmenopausal women with GSM appeared to lower in vaginal artery circulation and vaginal physical changes compared to non-GSM group.

Downloads

Download data is not yet available.

Author Biography

Patsira Warinsiriruk, Department of Obstetrics and Gynecology, Chaophrayayommarat Hospital Suphanburi

Medical Physician, Professional Level.

References

Kapoor E, Faubion SS, Kling JM, et al. Addressing menopause symptoms: barriers and burden in midlife women. Mayo Clin Proc. 2025;100(1):1897-907.

Faubion SS, Kapoor E, Kling JM, et al. Impact of menopause symptoms on women in the workplace. Mayo Clin Proc. 2023;98(6):817–29.

Gallo K, et al. Vaginal estrogen for genitourinary syndrome of menopause. JAMA Netw Open. 2025;8(12):e2549822.

สำนักงานเลขาธิการสภาผู้แทนราษฎร. สังคมผู้สูงอายุกับการขับเคลื่อนเศรษฐกิจไทย. กรุงเทพฯ: สำนักงานเลขาธิการสภาผู้แทนราษฎร; 2561.

Portman DJ, Gass MLS. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and the North American Menopause Society. Menopause. 2014;21(10):1063–8.

Erekson EA, Li F, Martin DK, Fried TR. Vulvovaginal symptom prevalence in postmenopausal women and relationship to other menopausal symptoms and pelvic floor disorders. Menopause. 2016;23(4):368–75.

Mitchell CM, Waetjen LE. Genitourinary changes with aging. Obstet Gynecol Clin North Am. 2018;45(4):737–50.

Hympanova L, Rynkevic R, Mori da Cunha MG, Deprest J. Vaginal changes after ovariectomy in ewes: a large animal model for genitourinary syndrome of menopause. Menopause. 2020;27(6):682–9.

Kingsberg SA, Wysocki S, Magnus L, Krychman ML. Vulvar and vaginal atrophy in postmenopausal women: findings from the REVIVE survey. Menopause. 2017;24(4):409–16.

Islam RM, Bell RJ, Green S, Page MJ, Davis SR. Safety and efficacy of testosterone for women: a systematic review and meta-analysis of randomised controlled trial data. Lancet Diabetes Endocrinol. 2019;7(10):754–66.

The North American Menopause Society. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. Menopause. 2013;20(9):888–902.

Weber MA, Limpens J, Roovers JPWR. Assessment of vaginal atrophy: a review. Int Urogynecol J. 2015;26(1):15–28.

Battaglia C, Battaglia B, Mancini F, Busacchi P, Paganotto MC, Morotti E, et al. Vaginal and clitoral vascularization in postmenopausal women: a color Doppler ultrasound study. Menopause. 2016;23(10):1094–9.

Lone F. Assessment of urethral vascularity using 2D colour Doppler high-frequency endovaginal ultrasonography in women treated for symptomatic stress urinary incontinence: 1-year prospective follow-up study. Int Urogynecol J. 2016;27(1):85–92.

Parish SJ, Nappi RE, Krychman ML, Kellogg-Spadt S, Simon JA, Goldstein JA, et al. Impact of vulvovaginal health on sexual function in postmenopausal women. J Sex Med. 2019;16(6):856–67.

Diedrich CM, Kastelein AW, Verri FM, Weber MA, Ince C, Roovers JPWR. Effects of topical estrogen therapy on the vaginal microcirculation in women with vulvovaginal atrophy. Neurourol Urodyn. 2019;38(5):1298–304.

Mitchell CM, Reed SD, Diem S, Larson JC, Newton KM, Ensrud KE, et al. Efficacy of vaginal estradiol or vaginal moisturizer vs placebo for treating postmenopausal vulvovaginal symptoms: a randomized clinical trial. JAMA Intern Med. 2018;178(5):681–90.

Downloads

Published

24-03-2026

How to Cite

1.
Warinsiriruk P. A Comparison of Vaginal Artery Vascularization in Postmenopausal Women with and without Genitourinary Syndrome of Menopause: A Cross-sectional Analytic Study. Singburi Hosp J [internet]. 2026 Mar. 24 [cited 2026 Mar. 28];35(1):B23-B33. available from: https://he01.tci-thaijo.org/index.php/shj/article/view/284291

Issue

Section

Research Articles